BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 12908375)

  • 21. Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps. A challenge-proven study.
    Bavbek S; Dursun AB; Dursun E; Eryilmaz A; Misirligil Z
    Int Arch Allergy Immunol; 2007; 142(1):64-9. PubMed ID: 17016059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspirin-sensitive asthma due to diffuse neuroendocrine system pathology.
    Evsyukova HV
    Neuro Endocrinol Lett; 2002 Aug; 23(4):281-5. PubMed ID: 12195225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity.
    Mastalerz L; Sanak M; Gawlewicz-Mroczka A; Gielicz A; Cmiel A; Szczeklik A
    Thorax; 2008 Jan; 63(1):27-34. PubMed ID: 17584993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin-induced asthma: from pathogenesis to therapy.
    Szczeklik A; Schmitz-Schumann M
    Allergol Immunopathol (Madr); 1993; 21(1):35-40. PubMed ID: 8328356
    [No Abstract]   [Full Text] [Related]  

  • 25. [Metabolic changes in arachidonic acid during aspirin desensitization].
    Salazar Villa RM; Zambrano Villa S
    Rev Alerg Mex; 1996; 43(3):56-61. PubMed ID: 8963642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases.
    Fraj J; Valero A; Vives R; Pérez I; Borja J; Izquierdo I; Picado C
    Allergy; 2008 Jan; 63(1):112-5. PubMed ID: 18053020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis.
    Higashi N; Taniguchi M; Mita H; Kawagishi Y; Ishii T; Higashi A; Osame M; Akiyama K
    J Allergy Clin Immunol; 2004 Feb; 113(2):277-83. PubMed ID: 14767442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Blood platelets and asthma caused by aspirin].
    Joseph M; Capron A; Ameisen JC; Martinot JB; Tonnel AB
    Allerg Immunol (Paris); 1987 Oct; 19(8 Suppl):7-10. PubMed ID: 3134035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene-expression profiles in human nasal polyp tissues and identification of genetic susceptibility in aspirin-intolerant asthma.
    Sekigawa T; Tajima A; Hasegawa T; Hasegawa Y; Inoue H; Sano Y; Matsune S; Kurono Y; Inoue I
    Clin Exp Allergy; 2009 Jul; 39(7):972-81. PubMed ID: 19489917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey.
    Bavbek S; Yilmaz I; Celik G; Aydin O; Erkekol FÖ; Orman A; Kurt E; Ediger D; Dursun B; Abadoğlu O; Ozşeker F; Akkaya E; Karakiş GP; Canbakan S; Yüksel S; Misirligil Z
    Allergol Immunopathol (Madr); 2012; 40(4):225-30. PubMed ID: 21889254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The broken balance in aspirin hypersensitivity.
    Szczeklik A; Sanak M
    Eur J Pharmacol; 2006 Mar; 533(1-3):145-55. PubMed ID: 16457808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma.
    Pujols L; Mullol J; Alobid I; Roca-Ferrer J; Xaubet A; Picado C
    J Allergy Clin Immunol; 2004 Oct; 114(4):814-9. PubMed ID: 15480320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arachidonic acid metabolism in nasal tissue and peripheral blood cells in aspirin intolerant asthmatics.
    Schmid M; Göde U; Schäfer D; Wigand ME
    Acta Otolaryngol; 1999 Mar; 119(2):277-80. PubMed ID: 10320091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal.
    Hinz B; Renner B; Brune K
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):552-60; quiz 1 p following 589. PubMed ID: 17906610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New pathophysiological concepts on aspirin hypersensitivity (Widal syndrome); diagnostic and therapeutic consequences].
    de Weck A; Sanz ML; Gamboa P
    Bull Acad Natl Med; 2005 Jun; 189(6):1201-18; discussion 1218-20. PubMed ID: 16433444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antileukotrienes in the therapy of bronchial asthma].
    Riccioni G; Della Vecchia R; Menna V; Lambo MS; Di Ilio C; D'Orazio N
    Recenti Prog Med; 2003 Nov; 94(11):509-15. PubMed ID: 14679921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selenium status in patients with aspirin-induced asthma.
    Hassan AM
    Ann Clin Biochem; 2008 Sep; 45(Pt 5):508-12. PubMed ID: 18753425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin and NSAID sensitivity.
    Stevenson DD
    Immunol Allergy Clin North Am; 2004 Aug; 24(3):491-505, vii. PubMed ID: 15242723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Aspirin-induced asthma].
    Sakakibara H
    Ryoikibetsu Shokogun Shirizu; 2000; (31):584-8. PubMed ID: 11269170
    [No Abstract]   [Full Text] [Related]  

  • 40. Obesity in aspirin-tolerant and aspirin-intolerant asthmatics.
    Jang AS; Park JS; Park SW; Kim DJ; Uh ST; Seo KH; Kim YH; Park HS; Park CS
    Respirology; 2008 Nov; 13(7):1034-8. PubMed ID: 18699807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.